High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial.

Massard, C.; Michiels, S.; Ferté, C.; le Deley, M.; Lacroix, L.; Hollebecque, A.; Verlingue, L.; Ileana, E.; Rosellini, S.; Ammari, S.; Ngo-Camus, M.; Bahleda, R.; Gazzah, A.; Varga, A.; Postel-Vinay, S.; Loriot, Y.; Even, C.; Breuskin, I.; Auger, N.; Job, B.; de Baère, T.; Deschamps, F.; Vielh, P.; Scoazec, J.; Lazar, V.; Richon, C.; Ribrag, V.; Deutsch, E.; Angevin, E.; Vassal, G.; Eggermont, A.; André, F.; Soria, J.

doi:10.1158/2159-8290.CD-16-1396

Public

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial.

Shared by NobleBlocks on Jun 1, 2017 • 12:00 AM UTC

Authors:

C. Massard

S. Michiels

C. Ferté

Abstract

High-throughput genomic analyses may improve outcomes in patients with advanced cancers. MOSCATO 01 is a prospective clinical trial evaluating the clinical benefit of this approach. Nucleic acids were extracted from fresh-frozen tumor biopsies and analyzed by array comparative genomic hybridization,...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!